<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-4WNICUDI</identifier><date>2021</date><creator>Proj, Matic</creator><creator>Toplak, Žan</creator><relation>documents/doc/4/URN_NBN_SI_doc-4WNICUDI_001.pdf</relation><relation>documents/doc/4/URN_NBN_SI_doc-4WNICUDI_001.txt</relation><format format_type="issue">1</format><format format_type="volume">72</format><format format_type="type">article</format><format format_type="extent">str. 44-50</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID_HOST">55511811</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-4WNICUDI</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">Podatkovne zbirke</subject><subject language_type_id="slv">računalniško podprto načrtovanje učinkovin</subject><subject language_type_id="slv">strojno učenje</subject><subject language_type_id="slv">Umetna inteligenca</subject><subject language_type_id="slv">Zdravila</subject><title>The use of artificial intelligence in drug discover</title><title>Uporaba umetne inteligence pri odkrivanju novih učinkovin</title></Record>